News
Two sides of the same coin: Measles-vectored drugs for cancer immunotherapy and vaccines
December 12, 2020
The CanVirex platform deploys the oncolytic properties of recombinant measles vectors for innovative cancer treatments. In addition it has now provided a novel COVID-19 vaccine
Behind CanVirex: From idea to realization
August 4, 2020
CanVirex stands for ‘fighting cancer with viruses’. Using viruses to treat cancer is an ancient idea, however only in recent decades technologies have been developed to investigate and modify these ’cancer-killing’, or ‘oncolytic’ viruses.